Pedro C. Lara Jiménez

Jefe Departamento Oncología

H.U. San Roque (Las Palmas)

CURRÍCULUM VITAE

Education:

1985 completion of medical studies at the University of Granada. Spain

1988 Ph.D. thesis University of Granada, Spain

1990 Radiation Oncology specialist Granada University Hospital,Spain

Professional experience/appointments:

1983-87 Research student/fellow Oncology Granada University Hospital, Spain 1987:1991Training in Radiation Oncology,Granada University Hospital, Spain

1987: Visiting trainee in Instituto de Tumori di Milano, Italy

1988: Visiting trainee in MD Anderson Cancer Center, USA

1990: Visiting trainee in Academisch Medisch Centrum, The Netherlands

1991-2008: Consultant Radiation Oncologist, Las Palmas University Hospital, Spain

1991-1995: Associate Professor of Radiation Oncology Las Palmas University, Spain

1995 Fellow Traslational Research, NKI, The Netherlands

1996: Full Professor of Radiation Oncology, Las Palmas University, Spain.

2001-onwards Member Canarian Institute for Cancer Research,Spain

2009-2018: Head, Radiation Oncology, Las Palmas University Hospital. Spain

2011-2016: President Ethic Committee Las Palmas University Hospital,Spain

2011-onwards: Director and Patron Canarian Institute for Cancer Research,Spain

2013-2018: Full Professor and Chair of Clinical Oncology and Hematology Las Palmas University,Spain .

2015-onwards: Director University Oncology Campus, SEOR/Francisco de Vitoria University Madrid Spain.

2018-onwards. Full Professor and Chair of Oncology and Radiotherapy Hematology Fernado Pessoa Canarias University ,Spain .

2018-onwards. Head, Oncology Dept, San Roque University Hospital. Spain

Professional membership & associations:

ASEICA(Spanish Assoc Cancer Research)

2008-12: Board of Directors

EACR (European Organization for Cancer Research)

2009-Onwards:Member

ESTRO (European Society for Radiotherapy and Oncology)

2015-to date: ESTRO Grants Committee

2015-to date: ESTRO Clinical Committee Member

2015-to date: ESTRO National Societies Committee Member

2018-onwards: HERO-ESTRO Spain Initiative Member

EORTC (European Organization for Research and Treatment of Cancer)

2013-to date: EORTC Radiation Oncology, Gynecology, Urology Groups Member

2015-to date: Liason member steering committee GU group

2014:EORTC GYN Group Meeting Las Palmas Local Organizer

2015:EORTC ROG Group Meeting Las Palmas Local Organizer

2017:EORTC GU Group Meeting Las Palmas Local Organizer

SEOR (Spanish Society Radiation Oncology)

2013-2015: SEOR Vice-president

2015-17: SEOR President

2017-2019: SEOR: Past President

2017-Onwards: Director Oncology University Campus SEOR//Fancisco de Vitoria University.

SEOC: (Spanish Society Clinical Oncology)

2015-Onwards: SEOC. Founder

2015-Onwards: SEOC. Secretary

FESEO (Spanish Federation of Oncological Societies)

2017-2019. Vice-president

UEMS (European Union of Medical Specialties)

2016-Onwards: UEMS Spanish representative Radiation/Clinical Oncology

2018-Onwards.President UEMS Radiation/Clinical Oncology Group

Research:

Member of the editorial board of Radiation Oncology, Reports of Practical Oncology and Radiotherapy, Clinical Traslational Oncology and Clinical and Traslational Radiation Oncology journals. He is actively publishing and reviewing scientific articles for several journals and participating in national and international scientific, educational and research meetings.

(Pubmed Lara PC, also Lara P,Lara-Jimenez, PC) H Index WOS:23

2020 publications

1.- Hypofractionated whole breast irradiation after IORT treatment: evaluation of acute toxicity and cosmesis.Clin Transl Oncol. 2020 May 22. In press

2.-Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 2020 Apr 25;23:27-29.

3.- Older Cancer Patients during the COVID-19 Epidemic: Practice Proposal of the International Geriatric Radiotherapy Group.Cancers (Basel). 2020 May 19;12(5):E1287.

4.-Accelerated partial breast irradiation with interstitial multicatheter brachytherapy after breast-conserving surgery for low-risk early breast cancer. Breast. 2020 Apr 22;52:45-49.

5.-EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. Eur Urol. 2020 Feb;77(2):223-250.

CIENTIFIX IVC_Logo mini_B-49

Primera y única plataforma digital científica y sanitaria. Entra y visibilízate con CIENTIFIX

Fondo_certificados-02

© 2020 Cientifix. Todos los derechos reservados.